Your ANSwer for Workers' Compensation Medical Cost Containment

  • Permalink Gallery

    ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

ANS Solutions, one of the nation’s leading providers of pharmacy cost containment services in the Workers Compensation industry, will feature the 2018 Renewal of its $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC in Las Vegas Nevada on December 6th, 2017 at BOOTH 2615.

Our program provides Workers Comp payers a guarantee on the life expectancy savings achieved via our “industry unique” pharmacy intervention process.  We assure our clients a $1 Million Dollar Savings per 10 Case Referral as part of a Pilot Program with the Company.  […]

By |December 4th, 2017|Pharmacotherapy Review|Comments Off on ANS Solutions to Feature 2018 Renewal of the $1 Million Dollar Performance Guarantee Program at the 2017 NWCDC

Opioid Rescue Therapy, Not Just A Quick Fix…

91 Americans lose their lives every day to opioid overdose, according to the Centers for Disease Control and Prevention (CDC).  That is over 33,000 Americans each year, and the rate is only rising, actually having quadrupled since 1999.  It is now accurately categorized as an Epidemic and, appropriately, stringent private and public institutional changes are being implemented to minimize the likelihood of future abuse.  This includes limited pill counts, prescription drug monitoring platforms, closed formularies, etc.  These improvements reduce the likelihood of future dependency, but what about those already […]

By |November 13th, 2017|Drug Utilization Review, Medical Cost Containment|Comments Off on Opioid Rescue Therapy, Not Just A Quick Fix…

National WC & Disability Conference December 4-7, 2018

Visit ANS Solutions in Booth #6337
National WC & Disability Conference

December 4-7, 2018
Mandalay Bay – Las Vegas, NV

By |April 17th, 2017|ANS News & Events|Comments Off on National WC & Disability Conference December 4-7, 2018

The Impact of Workers’ Compensation Compounding

As custom-made compound prescriptions concoctions continue to rack-up higher workers’ compensation costs, insurers are scrambling to find alternatives and employers are looking for relief from equally inflated premiums. With little to no evidence as to the efficacy of such creations, many states have implemented treatment guidelines directing doctors to more evidentiary-based, easily reimbursable options. Despite guidelines and formularies however, loopholes in coverage continue to allow providers to sell millions of dollars of compounds, with many companies submitting inflated reimbursement bills in their attempts to get paid.

A Growing Issue in […]

By |December 15th, 2016|Drug Utilization Review, Workers Compensation Industry|Comments Off on The Impact of Workers’ Compensation Compounding

New FDA Warning: Avoid Prescribing Opioids & Benzos Together

In a recent announcement by the FDA, boxed warning labels will now be required to advise against the utilization of prescription opioid pain medicines alongside benzodiazepines unless no other adequate alternative treatment method exists. Warnings about the risks of combining these two classes of drugs are nothing new. Already required on drug warning labels, additional black box warnings are an effort by the FDA to reach out to those who may have “missed the message.”

Classified as Central Nervous System (CNS) depressants, each drug alone can trigger side effects such […]

By |November 21st, 2016|Pharmaceutical Industry, Pharmacotherapy Review|Comments Off on New FDA Warning: Avoid Prescribing Opioids & Benzos Together
  • pharmacotherapy review ANS Solutions
    Permalink Gallery

    Prescription Drugs and the Workers’ Compensation Cost Containment Arena

Prescription Drugs and the Workers’ Compensation Cost Containment Arena

The U.S. remains the biggest global consumer of prescription drugs, up from around 76 million in 1991 to nearly 207 million in 2013 however a recent court ruling has called into direct question the prescription practices of physicians nationwide (Volkow).

The occurrence of unnecessary or medically inappropriate prescribing of opioids in pain management is compromising the lives and well-being of injured workers.  There are a number of serious issues concerning the use of opioids in pain management:

  • Not cost effective
    Evidence-based reviews are seldom consulted prior to the prescribing of opioids, and […]

By |November 7th, 2016|Pharmacotherapy Review, Workers Compensation Payers|Comments Off on Prescription Drugs and the Workers’ Compensation Cost Containment Arena

What’s Trending with California Workers’ Compensation

Though workers’ comp claims frequency is declining, a recently released California hospital report indicates claim severity is on the rise. Obtaining data from 35 hospitals and individual facilities, the Milliman and Keenan Healthcare report sourced more than 3,500 claims for review.

Trends identified in the report:

  • A decline in indemnity and medical-only claims, with ALAE costs playing an increasing role in overall claims costs in recent years. More specifically:
    • Higher average costs per indemnity for workers over 30.
    • Lesser average severity of indemnity claims in workers 30 and younger, with payments more likely […]
By |October 28th, 2016|Pharmacotherapy Review, Workers Compensation Payers|Comments Off on What’s Trending with California Workers’ Compensation

Why ANS Pharmacotherapy Review is so Effective

The prescription pain medication crisis is taking its toll across the U.S. Costs are extreme, with a broad array of collateral damage fanning out from those effected to families and industries, among the hardest hit, workman’s comp. So extreme are the effects of addictive and deadly prescription opioids, even the Federal Government has taken notice, with the CDC stepping in to release new opioid prescribing best practices earlier this year in hopes of ushering in a new era for an ailing nation. The issue is out in the open. […]

By |October 17th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Why ANS Pharmacotherapy Review is so Effective

Bipartisan Opioid Abuse Bill

In an effort to reverse the rapidly rising death toll from heroin, prescription drugs, and opioids across the U.S. which has recently risen to surpass automobile accidents as the leading cause of injury-related deaths according to the CDC, legislation has been drafted in a rare bipartisan effort.

The Comprehensive Addiction and Recovery Act (CARA)
Designed to strengthen prescription drug monitoring programs, better trace the diversion of opioid drugs, and increase promotion and access to addiction recovery services, CARA will also open up a variety of prevention and treatment avenues:

  • Prevention and […]
By |September 26th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Bipartisan Opioid Abuse Bill

Patient Engagement and Prescription Drug Label Enhancements

Upcoming improvements to prescription drug labeling are hoped to positively affect patient care across the board. Intentionally kept in the dark on the ingredients and indications of prescription drugs for well-over 100 years, the healthcare industry is shifting from the past’s blind trust to finally realizing today’s modern paradigm: Engaging patients as active participants in their own healthcare endeavors.

Small Label, Big Impact
Improving the synchronization between in-office care and home care, the FDA’s latest labeling procedures will not only help patients under a physician’s care better understand why each medication […]

By |September 12th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Patient Engagement and Prescription Drug Label Enhancements